Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
24 25 Next >
Philips Reports Q4 Earnings, To Lay Off Additional Employees This Year, Shares Jump
Tickers NVS PHG
Tags why it's moving NVS Market News
From Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
Tickers AAPL AMD AMGN AMZN
Tags KLAC BZH F
From Benzinga
Could This Be Novartis' Next Blockbuster Medicine?
Tickers AZN NVS
Tags Market News Recent Press Releases NVS
From Motley Fool
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
Tickers ALPMF ALPMY GSK NVS
Tags Health Care GSK ALPMY
From Benzinga
3 Drug Stocks With Promising Pipelines for 2023
Tickers BMRN LLY NVO NVS
Tags NVS NYSE:NVS,NASDAQ:BMRN,NYSE:LLY,NYSE:NVO Market News
From InvestorPlace
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
Tickers BSX CMND ICL INTC
Tags BSX Global Next/Generation Psychedelics
From Benzinga
Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide
Tickers AMGN LLY NVO NVS
Tags PFE Price Target Briefs
From Benzinga
Novartis CEO Refutes Recent Report Of Weighing Options For Ophthalmology, Respiratory Units
Tickers NVS
Tags Large Cap Briefs News
From Benzinga
3 Biotech Companies to Watch in 2023
Tickers GMAB HZNP NVS UTHR
Tags VRTX UTHR HZNP
From InvestorPlace
2 Top Biotech Stocks to Buy Right Now
Tickers BNTX NVS PFE
Tags NVS Recent Press Releases Market News
From Motley Fool
GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca
Tickers GSK NVS
Tags Rumors General NVS
From Benzinga
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
Tickers ARKG CRSP INCY NVS
Tags ARKG CRSP VRTX
From Motley Fool
Elon Musk Tells Employees Tesla Will Be 'Most Valuable Company On Earth, Sam Bankman-Fried Set To Enter Plea On Fraud Case, Twitter 'Should Feel Faster': Today's Top Stories
Tickers AAPL AMZN BYDDF BYDDY
Tags Large Cap WBD TSLA
From Benzinga
Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug
Tickers CVS ENDPQ KR NVS
Tags Legal ENDPQ General
From Benzinga
Hopeful Golden Cross Forms On Novartis's Chart
Tickers NVS
Tags Markets NVS BZI/CROSS
From Benzinga
5 Value Stocks In The Healthcare Sector
Tickers ABOS HUMA ITOS NVS
Tags Benzinga ITOS HUMA
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ALGN EXAS GH LLY
Tags BZI/AUOA Options LLY
From Benzinga
A Bullish Sign Appears On Novartis's Chart
Tickers NVS
Tags Movers Benzinga Trading Ideas
From Benzinga
3 Ridiculously Cheap Dividend Stocks That Yield More Than 3%
Tickers CM INTC NVS
Tags Market News Recent Press Releases NVS
From Motley Fool
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
Tickers AZN GILD LLY MDGL
Tags PFE Briefs Price Target
From Benzinga
Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
Tickers ABMD HZNP NVO NVS
Tags Market News NVS Markets
From Benzinga
A Career Politician Who Regularly Trades The SPY, Picked Up There 3 High Yielding ETFs Instead
Tickers ABT BAC BHP CMCSA
Tags WFC Politics Rob Wittman Stock Trades
From Benzinga
Novartis Shares Detailed Results From Experimental Drug For Rare Blood Disorder
Tickers NVS
Tags Briefs Benzinga Biotech
From Benzinga
CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy
Tickers CLVS CTM NVS RIVN
Tags NVS Market News RIVN
From InvestorPlace
Erasca Oulicenses Its Mid-Stage Cancer Program To Novartis, Raises $100M Via Equity Offering
Tickers ERAS NVS
Tags Benzinga Biotech Movers
From Benzinga
Novartis' Rare Blood Disorder Therapy Aces Second Late-Stage Trial
Tickers NVS
Tags Briefs Large Cap News
From Benzinga
3 Hot Stocks That Could Live Up to Their Lofty Valuations
Tickers ABBV GMAB GTBIF JNJ
Tags RHHBY GMAB Market News
From Motley Fool
MorphoSys Inks Licensing Agreement With Novartis For Preclinical Cancer Programs
Tickers MOR NVS
Tags Briefs MOR Benzinga
From Benzinga
Novartis' Kisqali Prolongs Progression Free Survival Benefit In Metastatic Breast Cancer Versus Chemo
Tickers NVS
Tags News Large Cap Briefs
From Benzinga
Novartis prostate cancer drug trial meets primary endpoint
Tickers NVS
Tags NVS CH:NOVN
From MarketWatch
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.